Signup Crypto ETF Stocks News

Celldex Therapeutics Presents Positive Preclinical Data from Inflammatory Bispecific Antibody Program CDX-622 at AAAAI 2025

- CDX-622 inhibits SCF and TSLP-dependent inflammatory signatures in human skin -- Phase 1 study in healthy volunteers ongoing ...

Source: www.globenewswire.com
March 03, 2025 | 13:01:00
Category: News

Nasdaq Stockholm approved the delisting of Millicom ( Tigo ) SDRs and set the last day of trading on March 17, 2025

Nasdaq Stockholm approved the delisting of Millicom ( Tigo ) SDRs and set the last day of trading on March ...

Source: www.globenewswire.com
March 03, 2025 | 13:19:00
Category: News

Ascot Announces Amendment of Previously Announced Equity Financing

Not for distribution to U.S. news wire services or dissemination in the United States.

Source: www.globenewswire.com
March 03, 2025 | 13:20:00
Category: News

Binance to Delist Tether and Other Stablecoins for EEA Users, Due to MiCA Regulations

The news of Tether's delisting comes as the firm appoints a new CFO in a "historic step" towards a full financial audit.

Source: decrypt.co
March 03, 2025 | 13:20:28
Category: News

Odysight.ai to Participate at the 37th Annual ROTH Conference on March 17-18, 2025

Omer, Israel, March 03, 2025 ( GLOBE NEWSWIRE ) -- Odysight.ai Inc. ( Nasdaq: ODYS ) , a pioneering developer of AI systems for Predictive Maintenance ( PdM ) and Condition-Based Monitoring ( CBM ) , today announced its participation at the 37th Annual ROTH Conference on March 17-18, 2025, in ...

Source: www.globenewswire.com
March 03, 2025 | 13:25:00
Category: News

Synchronoss Unveils Capsyl Cloud at MWC Barcelona - A Turn-Key Personal Cloud Solution for Global Operators

Empowering Mobile Operators and Service Providers to Rapidly Launch and Monetize Consumer Cloud Services ...

Source: www.globenewswire.com
March 03, 2025 | 13:30:00
Category: News

Nexalin Technology Receives Notice of Allowance from the USPTO for Patent Covering Deep Intracranial Frequency Stimulation ( DIFS™ ) Technology for Opioid and Other Substance Use Disorders

Patent Strengthens Nexalin's Intellectual Property Portfolio and Highlights the Potential of DIFS™ Technology in Addressing Substance Use Disorders, Including Opioids, Alcohol, Cocaine and Methamphetamine Patent Strengthens Nexalin's Intellectual Property Portfolio and Highlights the Potential ...

Source: www.globenewswire.com
March 03, 2025 | 13:30:00
Category: News

Coherus to Report Fourth Quarter and Full Year 2024 Financial Results on March 10, 2025

REDWOOD CITY, Calif., March 03, 2025 ( GLOBE NEWSWIRE ) -- Coherus BioSciences, Inc. ( "Coherus," NASDAQ: CHRS ) today announced that its fourth quarter and full year 2024 financial results will be released after market close on Monday, March 10, 2025. Starting at 5:00 p.m.

Source: www.globenewswire.com
March 03, 2025 | 13:30:00
Category: News

Allogene Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update

SOUTH SAN FRANCISCO, Calif., March 03, 2025 ( GLOBE NEWSWIRE ) -- Allogene Therapeutics, Inc. ( Nasdaq: ALLO ) , a clinical-stage biotechnology company pioneering the development of allogeneic CAR T ( AlloCAR T™ ) products for cancer and autoimmune disease, today announced that it will report ...

Source: www.globenewswire.com
March 03, 2025 | 13:30:00
Category: News

uCloudlink Unveils Groundbreaking Innovations at MWC 2025: Redefining Connectivity for IoT, People, and Pets - Ucloudlink Group ( NASDAQ:UCL )

BARCELONA, Spain, March 3, 2025 /PRNewswire/ -- uCloudlink UCL, the world's first and leading mobile data traffic-sharing marketplace, is thrilled to announce its participation in MWC 2025, where it will showcase its latest innovations in connectivity.

Source: www.benzinga.com
March 03, 2025 | 11:20:00
Category: News

© Natavest 2025 - 2026